Lv41
770 积分 2025-09-11 加入
Childhood nephrotic syndrome--current and future therapies
1小时前
待确认
Anti-nephrin autoantibodies: a paradigm shift in podocytopathies
8天前
已完结
Telitacicept: First Approval
10天前
已完结
Telitacicept for IgA Nephropathy — Interim Analysis of a Phase 3 Trial
17天前
已完结
Resetting autoimmune disease with CAR cell therapies
22天前
已完结
Telitacicept for IgA Nephropathy — Interim Analysis of a Phase 3 Trial
1个月前
已完结
Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial
2个月前
已完结
Efficacy and safety of belimumab in IgA nephropathy: real-world evidence
3个月前
已关闭
Natural History and Clinical Associations with Long-Term Outcomes in Primary C3 Glomerulopathy and Immune Complex-Mediated Membranoproliferative GN
3个月前
已关闭
Treatment Response Rates and Kidney Outcomes among Adults with Primary FSGS
3个月前
已关闭
皖公网安备34019202002308
